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Abstract
Rationale—Among the extracellular modulators of Bmp (bone morphogenetic protein)
signaling, Bmper (Bmp endothelial cell precursor-derived regulator) both enhances and inhibits
Bmp signaling. Recently we found that Bmper modulates Bmp4 activity via a concentration-
dependent, endocytic trap-and-sink mechanism.
Objective—To investigate the molecular mechanisms required for endocytosis of the Bmper/
Bmp4 and signaling complex and determine the mechanism of Bmper’s differential effects on
Bmp4 signaling.
Methods and Results—Using an array of biochemical and cell biology techniques, we report
that LRP1 (Low density lipoprotein receptor-related protein 1), a member of the LDL receptor
family, acts as an endocytic receptor for Bmper and a co-receptor of Bmp4 to mediate the
endocytosis of the Bmper/Bmp4 signaling complex. Furthermore, we demonstrate that LRP1-
dependent Bmper/Bmp4 endocytosis is essential for Bmp4 signaling, as evidenced by the
phenotype of lrp1-deficient zebrafish, which have abnormal cardiovascular development and
decreased Smad1/5/8 activity in key vasculogenic structures.
Conclusions—Together, these data reveal a novel role for LRP1 in the regulation of Bmp4
signaling by regulating receptor complex endocytosis. In addition, these data introduce LRP1 as a
critical regulator of vascular development. These observations demonstrate Bmper’s ability to
fine-tune Bmp4 signaling at the single-cell level, unlike the spatial regulatory mechanisms applied
by other Bmp modulators.
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INTRODUCTION
Bone morphogenetic proteins (Bmps) are essential for embryonic vascular development, as
illustrated by many severe, inherited vascular diseases associated with disrupted Bmp
signaling1. One facet of regulation of Bmp signaling is provided by extracellular molecules
that “fine-tune” Bmp signaling by modulating (usually inhibiting) Bmp’s interaction with
surface receptors and subsequent downstream signaling events2. Of these extracellular
modulators of Bmp signaling, Bmper (Bmp-binding endothelial cell precursor-derived
regulator, the vertebrate ortholog for crossveinless-2 (Cv-2) in Drosophila) is a critical
determinant of endothelial functions such as differentiation, migration and angiogenesis3–6.
Bmper can both promote and inhibit Bmp activity6, 7, confounding the development of a
working model to explain how Bmper impacts Bmp signaling. However, we recently found
that Bmper modulates Bmp4 activity via a concentration-dependent, endocytic trap-and-sink
mechanism, with low levels of Bmper promoting and high levels inhibiting Bmp4 signaling,
thereby accounting for the biphasic nature of Bmper’s regulation of Bmp4 activity7. Our
previous data suggested that endocytosis of the Bmper/Bmp4 complex may be critical in
determining the inhibitory effect of Bmper on Bmp4 function. However, gaps remained in
understanding how activation and inhibition of Bmp4 signaling by Bmper were coupled and
the mechanism by which the Bmper/Bmp4 complex was endocytosed.
Here we report that LRP1 (Low density lipoprotein receptor-related protein 1) is a novel
endocytic receptor for Bmper and a co-receptor of Bmp4 that is essential for mediating
Bmp4 signaling. A requisite role for LRP1 in zebrafish angiogenesis is observed in that
knockdown of lrp1 decreases Smad1/5/8 activity and abnormal cardiovascular development.
Together, these data demonstrate that LRP1 regulates Bmp4-mediated endothelial function
and vascular development in vivo and is therefore a bone fide component of the Bmp
signaling pathway.
METHODS
Generation of cell lines
For stable MEC cell line construction, MECs were transduced with LRP1 or control shRNA
lentiviral particles, and positive colonies were screened with puromycin and evaluated by
Western blot analysis.
Chemical cross-linking in intact cells, immunoblotting, immunoprecipitation and ligand
blotting
Bmper-treated MECs were crosslinked with dithiobis(succinimidylproprionate)(DSP) for
immunoprecipitation and MALDI-TOF analysis. Immunoblotting, immunoprecipitation and
Ligand blotting were performed following our previous protocols7–8.
FRET experiments
Experiments were performed following a previously published protocol9. Donor, acceptor
and FRET images were acquired sequentially using fixed excitation and emission filters, and
image processing was performed.
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In vitro Matrigel tubulogenesis assay
Endothelial cell tube formation was analyzed with the Matrigel-based tube formation
assay10.
Morpholino injections and zebrafish analysis
Morpholino oligonucleotides (MOs) were produced by Gene Tools (Philomath, OR). All
MOs were injected into one to four cell stage embryos as previously described11. Zebrafish
(Danio rerio) vascular development was analyzed following previously published
methods12.
Please see the expanded Methods section, available in the Online Data Supplement for
details regarding reagents, cell culture, immunoblotting, ligand blotting,
immunofluorescence, and statistical analysis.
RESULTS
LRP1 associates with Bmper in MECs
Previously we demonstrated that endocytosis of the Bmper/Bmp4 complex is critical for
Bmper-mediated Bmp4 signaling7. However, the mechanism governing this endocytosis
remained unclear. Hypothesizing that Bmper may interact with a partner to achieve
endocytosis, we used matrix-assisted laser desorption/ionization-time of flight (MALDI-
TOF) mass spectrometry as an inductive unbiased method of identifying Bmper-associated
proteins in mouse endothelial cells (MECs). LRP1, a well-defined endocytic receptor,
associated with Bmper in MECs (Figure 1A; Online Figure IA and Table I). Confocal
imaging of Bmper-treated MECs revealed that Bmper and LRP1 colocalize on the plasma
membrane and in intracellular vesicles (Figure 1B). Immunoprecipitating for LRP1 and
immunoblotting for Bmper (or the reverse, or Bmper ELISA) demonstrated that full-length
Bmper associates with LRP1 in MEC lysates (Figure 1C; Online Figure IB, C), confirming
our MALDI-TOF and immunofluorescence data. Notably, this association was not affected
by the addition of Bmps (Online Figure ID, E). Since Bmp4 may bind Bmper through its
amino-terminal domain (NTD)7, 13, its inability to disrupt the LRP1/Bmper association
suggested that LRP1 may bind a different domain of Bmper and carboxyl-terminal domain
(CTD) fragments of Bmper associated with LRP1 (Figure 1C; Online Figure ID), indicating
that Bmper may form a ternary complex with LRP1 and Bmp4 through respective
associations with its CTD and NTD. Consistent with this hypothesis, lysates of Bmp4-
treated MECs immunoprecipitated with an anti-LRP1 antibody revealed the presence of
LRP1/Bmp4 heterocomplexes (Online Figure IF).
Like other members of the LDL receptor family, LRP1 is a heterodimer composed of a 515-
kDa α chain possessing four extracellular ligand binding domains (LBDs) and an 85-kDa
membrane-anchored β chain14. Ligand blotting analysis with full-length LRP1 revealed that
Bmper associates with both the α and β chains of LRP1 (Figure 1D). To determine which
LBD of LRP1 is required for binding to Bmper, cells were transfected with membrane-
containing mini-LRP1 receptors (mLRP1~415; Figure 1E, left panel) and analyzed via
ligand blotting. LBDIII/IV exhibited the strongest association with Bmper, whereas LBDII
had only a weak association and LBDI did not associate with Bmper at all (Figure 1E, right
top panel), consistent with what is found with other LRP1 ligands such as RAP115.
However, Bmper also binds to the β chain of LRP1, making Bmper unique among other
known LRP1 ligands. The significance of Bmper binding to LRP1’s β chain remains
unknown; however, internalized CTD fragments of Bmper may bind LRP1 and modulate its
association with scaffold proteins that participate in LRP1-dependent signaling
mechanisms16. Together, these data identify that LRP1, a recognized endocytic receptor,
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associates with Bmper in MECs and therefore could be responsible for endocytosis of
Bmper/Bmp4 complexes.
LRP1 is required for physiologic Bmper internalization
Previously, we found that Bmper undergoes endocytosis via an unknown mechanism that
modulates downstream Bmp4 signaling7. Given our observation of a direct interaction
between Bmper and the endocytic receptor-LRP1, we hypothesized that LRP1 may act as an
endocytic receptor for Bmper and examined cell lysates from LRP1-knockdown (or control)
MECs treated with Bmper. The level of internalized Bmper in control MECs increased over
time, peaking at 60 min and subsequently decreased, probably due to degradative
processing, as previously demonstrated7 (Figure 2A, B). LRP1-knockdown MECs also
demonstrated a time-dependent increase in Bmper internalization; however, internalization
was substantially less than in control MECs (Figure 2B). When cells were treated with
increasing doses of Bmper, the presence of cytoplasmic Bmper in control MECs increased,
an effect that was significantly decreased in LRP1-knockdown cells (Figure 2C, D). Similar
results were observed in MEFs (Online Figure IIA-D). These data suggest that the majority,
but not all, of Bmper is via an LRP1-dependent mechanism and we further explored the role
that LRP1 plays in Bmper/Bmp4 endocytosis.
We used confocal microscopy to investigate whether LRP1 is involved in the previously
reported internalization and transport of Bmper to endosomes7. Following Bmper
internalization, both LRP1 and Bmper were detected in a subset of vesicles expressing
EEA-1 and Rab-7 (endosome markers; Online Figure IIE, F). LRP1-knockdown MECs
contained far fewer Bmper-containing EEA-1 and Rab-7 positive endosomal vesicles
compared to control MECs (Figure 2E and data not shown). Similar results were found in
LRP1 null MEFs (Online Figure IIG). Further subcellular fractionation experiments
confirmed this localization (Online Figure IIH). These data collectively indicate that LRP1
influences the endosomal localization of Bmper and acts as an endocytic receptor for
Bmper. We have previously shown that Bmper is internalized in a complex together with
Bmp4 and Bmp receptors and that endocytosis of this holocomplex is critical for modulating
Bmp4 signaling7. Therefore, we next investigated whether the interaction between LRP1
and Bmp receptors could influence Bmp4-dependent Smad1/5/8 signaling in endothelial
cells.
LRP1 is associated with Bmp receptor type IB/ALK6
LRP1 functions as a co-receptor for ligands such as transforming growth factor (TGF) β and
NMDA17, 18. Given our data demonstrating that LRP1 is an endocytic receptor for Bmper,
we hypothesized that LRP1 may act as a co-receptor of Bmp receptors. There are multiple
Bmps (Bmp2, 4, 6) and Bmp type I receptors (ALK1, 2, 3 and 6) in MECs and specific
siRNA knockdown of ALK2, 3, and 6 (but not ALK1) inhibited Bmp4-induced Smad1/5/8
phosphorylation (Online Figure IIIA-C). Given our previous data identified ALK6 as a
Bmp4 type I receptor that mediates Bmp-dependent endothelial migration and
angiogenesis10, we used ALK6 as a representative Bmp type I receptor in the following
experiments. Fluorescence energy transfer (FRET) imaging analysis demonstrated the close
proximity of CFP-tagged ALK6 (Figure 3A) and YFP-tagged mLRP2 in cytoplasmic
vesicles and plasma membranes of transfected cells (Figure 3B), indicating that LRP1 and
ALK6 could physically interact in cells. Co-immunoprecipitation of lysates from cells
transfected with a wild-type ALK6 plasmid (ALK6-WT; Figure 3A) and each mLRP
construct (Figure 1E) confirmed this association (Figure 3C). Additionally, when cells were
transfected with a LRP1β construct (Figure 3A), the LRP1 and ALK6 association persisted
(Figure 3D), indicating that this association likely occurs through the LRP1β chain. Because
Bmper could bind to this region of LRP1 (Figure 1D), this interesting observation suggests
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that both Bmper and Bmps influence LRP1 signaling, thereby initiating cross-talk between
the LRP1 and Bmp signaling pathways.
To determine the domains of ALK6 involved in the interaction with LRP1, ALK6 deletion
mutants were constructed (Figure 3A). Both ALK6-CTD and ALK6-PKD co-
immunoprecipitated with mLRP2, indicating that the cytoplasmic region of ALK6 is
required for the association of ALK6 with mLRP2 (Figure 3E). However, the association of
mLRP2 with ALK6-CTD and PKD was decreased in comparison to mLRP2 binding to
ALK6-WT, suggesting that CTD of ALK6 is required but not sufficient for the association
with mLRP2. Similar results were observed with the interaction of ALK6 and mLRP4
(Online Figure IIID). Collectively, we conclude that the intracellular domains and possible
membrane region of ALK6 are required for the association with LRP1. Because the PKD of
ALK6 is critical for downstream Bmp-mediated Smad1/5/8 phosphorylation19, next we
tested whether the ALK6 and LRP1 interaction was involved in Bmp4-regulated Smad1/5/8
signaling induced by Bmper.
Endocytosis of the Bmper/Bmp4 complex is required for both stimulatory and inhibitory
regulation of Bmp4 signaling by Bmper
We previously demonstrated that endocytosis of the Bmper/Bmp4 complex is required for
the inhibitory effect of Bmper on Bmp4 signaling7, but whether endocytosis of the Bmper/
Bmp4 complex is also required more generally for Bmper-dependent Bmp4 signaling
regulation remained unclear. Therefore, we used three endocytosis inhibitors -
chlorpromazine (CPM), chloroquine (CQ), bafilomycin A1 (BafA1) - in MECs and
evaluated the subsequent effect on Bmp4-dependent phosphorylation of Smad1/5/8.
Treatment of MECs with Bmp4 alone or in the presence of substoichiometric concentrations
of Bmper increased Smad1/5/8 phosphorylation (Figure 4A, lane 2, 4, 12 and 14; Online
Figure IVA), consistent with our previous observations that substoichiometric ratios of
Bmper to Bmp4 enhances Bmper-dependent Bmp4 signaling7. However, when cells were
pretreated with CPM to prevent clathrin-mediated endocytosis, the level of Smad1/5/8
phosphorylation induced by either Bmp4 alone or Bmp4 plus Bmper in substoichiometric
concentrations was substantially decreased (Figure 4A, lane 7, 9; Online Figure IVB),
indicating that Bmper-mediated enhancement of Bmp4 signaling requires endocytosis of the
Bmper/Bmp4 complex. Next we investigated whether Rab4-mediated rapid recycling is
required for Bmper’s promoting effect on Smad1/5/8 phosphorylation. Rab4 siRNA
knockdown resulted in a significant decrease in Smad1/5/8 phosphorylation induced by
Bmp4 alone or Bmp4 plus Bmper in substoichiometric concentrations (Figure 4B, Online
Figure IVC). This suggests that the Rab4-mediated rapid recycling route is required for both
Bmp4 activity and the promoting effect of Bmper at stoichiometric concentrations. This
observation, combined with our previous data demonstrating that endocytosis is also
necessary for the inhibition of Bmp4 signaling caused by suprastoichiometric concentrations
of Bmper in the Bmper/Bmp4 complex7, indicates that endocytosis is required for all aspects
of Bmper-mediated regulation of Bmp4 signaling.
We next examined the effect that CQ and BafA1 had on Bmper-mediated Bmp4 signaling.
Treatment of cells with CQ did not affect the ability of Bmp4 alone or Bmp4 plus Bmper in
substoichiometric concentrations to induce Bmp4-mediated Smad1/5/8 phosphorylation
(Figure 4A, lane 17, 19; Online Figure IVD). However, CQ treatment relieved the inhibitory
effect of Bmp4 in the presence of suprastoichiometric concentrations of Bmper, resulting in
augmented Smad1/5/8 phosphorylation (Figure 4A, compare lanes 15 and 20). A similar
effect on Smad1/5/8 phosphorylation was obtained with BafA1 pretreatment (Online Figure
IVE). Since CQ and BafA1 prevent endosomal acidification and inhibit endosome fusion
and lysosomal degradation, our data suggest that the inhibition of Bmp signaling by
suprastoichiometric concentrations of Bmper involves the lysosomal degradation of the
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Bmper/Bmp4/BMPR complex, and not simply endocytosis of the signaling complex as
previously thought7. Collectively, these data demonstrate that endocytosis is a crucial
process linked to Bmper’s ability to both activate and inhibit Bmp4 signaling. In addition,
the inhibitory effect of suprastoichiometric concentrations of Bmper on Bmp4 signaling may
involve the lysosomal degradation of the Bmper/Bmp4 signaling complex.
LRP1 is required for Bmper/Bmp4-dependent signaling
We next examined the role that LRP1 plays in Bmper-dependent Bmp4 signaling. Following
treatment with Bmp4 and Bmper, Smad1/5/8 phosphorylation was evaluated in LRP1-
knockdown MECs. Not surprisingly, LRP1-knockdown inhibited Bmper and Bmp4
internalization in these cells (Figure 4C) and decreased Smad1/5/8 phosphorylation induced
by Bmp4 alone and by Bmp4 plus Bmper in substoichiometric concentrations (Figure 4C,
lane 7, 9; Online Figure IVF), supporting that endocytosis is required for Bmper-dependent
enhancement of Bmp4 signaling. Interestingly, LRP1-knockdown in MECs relieved the
inhibitory effect of suprastoichiometric concentrations of Bmper on Bmp4-dependent
Smad1/5/8 phosphorylation (Figure 4C, lane 10), proving that LRP1 mediates the inhibitory
effect of suprastoichiometric concentrations of Bmper on Bmp4 signaling. These data
demonstrate the pivotal role that LRP1 plays in Bmper-mediated Bmp4 signaling and
support the theory that endocytosis of the Bmper/Bmp4 complex is essential for both the
stimulatory and inhibitory actions that Bmper exerts on Bmp4 signaling.
To activate Bmp signaling, Bmp receptor (BMPR) I/II heterodimers must form before
Smad1/5/8 phosphorylation occurs20. Having established that LRP1 is required for Bmper-
dependent regulation of Bmp4 signaling, we tested the involvement of LRP1 in the
regulation of ALK6/BMPRII heterodimerization. ALK6/BMPRII heterodimers were
detected in control MECs under basal conditions (Figure 4D, lane 1) with the level
increasing steadily with the addition of Bmp4, or Bmp4 plus substoichiometric
concentrations of Bmper (Figure 4D, lane 2 & 4; Online Figure IVG). In contrast, when
cells were treated with Bmper alone or suprastoichiometric ratios of Bmper to Bmp4, the
level of ALK6/BMPRII heterodimerization was similar to that seen under basal conditions
(Figure 4D, lane 5). Surprisingly, in LRP1-knockdown MECs, the decrease of LRP1 protein
level resulted in a greater abundance of ALK6/BMPRII heterodimers in the basal state
(Figure 4D, comparing lane 6 to 1), suggesting that LRP1 competes with BMPRII for
association with ALK6. In contrast, when LRP1-knockdown MECs were treated with
Bmp4, Bmper, or Bmp4 and both low and high concentrations of Bmper, ALK6/BMPRII
heterodimers were decreased in abundance (Figure 4D, lanes 7–10, compared to lane 6).
These data suggest that LRP1 regulates the interaction of ALK6 with BMPRII under both
basal and stimulated conditions – blocking the association of the receptors in the absence of
Bmp4 or Bmper and promoting receptor interaction once stimulation with Bmp4 and/or
Bmper at substoichiometric concentrations occurs. Other Bmp type II receptors (e.g., activin
receptor type II) showed different behavior in response to LRP1 (Online Figure IVH). In
addition, the binding of ALK6 and BMPRII was similar but not same in MEFs (Online
Figure IVI). Because exogenous mLRPs and ALK6 were associated in HEK293 cells
(Figure 3), we wanted to know whether they form a complex in MECs and, if so, how
Bmper/Bmp4 affect this association. Immunoprecipitation assays using MEC lysates
confirmed that ALK6 and LRP1 were associated in MECs. Whereas their interaction was
inhibited by Bmp4, it was increased by treatment with Bmper alone, or Bmp4 and Bmper at
both sub- and suprastoichiometric concentrations (Figure 4E, Online Figure IVJ), suggesting
that the LRP1 and ALK6 association is dynamically regulated by Bmp4 and Bmper, which
may explain the differential effects of Bmper at sub-or suprastoichiometric concentrations
on Smad1/5/8 activation.
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LRP1 regulates Bmper/Bmp4-dependent endothelial migration and angiogenesis
Our data demonstrating that LRP1 is required for the Bmper-mediated Bmp4 signaling
module suggests that LRP1 could influence physiological outcomes of Bmper-mediated
Bmp4 signaling such as endothelial migration and angiogenesis. In Boyden chamber
migration assays, both Bmp4 and Bmper enhanced endothelial migration in MECs whereas
a Bmp4 neutralizing antibody blocked Bmp4-induced cell migration (Online Figure IVK,
L), consistent with previous reports3, 21. However, LRP1 knockdown in MECs completely
inhibited migration induced by Bmp4, Bmper alone or Bmp4 plus a substoichiometric
concentration of Bmper. Furthermore, LRP1 knockdown in MECs relieved the inhibition on
cell migration caused by the combined treatment of Bmp4 plus suprastoichiometric
concentrations of Bmper, consistent with our finding that the inhibition of Smad1/5/8
phosphorylation induced by high concentrations of Bmper was also relieved in the absence
of LRP1 (Figure 4C). To study the role of LRP1 in angiogenesis, we performed an in vitro
Matrigel tubulogenesis assay. Similar to the effects on endothelial migration, LRP1
knockdown in MECs blocked tube formation induced by Bmp4, Bmper or the cotreatment
of Bmp4 plus Bmper at the substoichiometric concentrations (Figure 4F). However, LRP1-
knockdown MECs demonstrated increased tube formation upon the treatment of Bmp4 and
Bmper at suprastoichiometric concentrations (Figure 4F). These data establish that the
biochemical model we constructed through in vitro analysis holds true in a physiologically
relevant cellular setting, demonstrating that LRP1 is a critical determinant of Bmper-
mediated Bmp4 signaling events.
LRP1 is necessary for cardiovascular development in zebrafish
The fact that Bmper/Bmp signaling pathways are essential for vascular development in
zebrafish5, 12, along with our observations of a clear reliance of Bmper-mediated Bmp4
signaling on LRP1, prompted us to test whether LRP1 may also play an important role in
Bmp4-dependent cardiovascular development. The spatiotemporal expression of lrp1 during
zebrafish embryonic development was examined. Weak lrp1a expression was observed at 12
hours post fertilization (hpf), whereas a stronger, symmetrical expression signal could be
detected at the lateral dorsal aorta (LDA) at 24 hpf and other vascular structures at later time
points (Figure 5A, Online Figure VA). Interestingly, the expression pattern of lrp1a closely
paralleled that of bmper5, in that lrp1a was expressed in structures that have Bmp and
vasculogenic activity, such as LDA and dorsal longitudinal anastomotic vessel (DLAV).
To determine the importance of lrp1a in vasculogenesis, we utilized lrp1a-specific
morpholino oligonucleotides (MOs) to knock down lrp1a during zebrafish embryonic
development. lrp1a knockdown efficiently decreased embryonic levels of lrp1a RNA as
determined by RT-PCR (Online Figure VB) and resulted in an abnormal vascular
phenotype, illustrated by delayed dorsal and intersegmental vessel formation, fewer vascular
branches within the caudal vein plexus, and a large swollen vascular lumen with ectopically-
placed Kdr+ cells (Figure 5B), which have also been described for bmper morphants5.
Additionally, lrp1a morphants demonstrated disrupted blood flow and a slower or stopped
heart beat (dsRed images in Online Figure VC and Table III). Increased doses of lrp1a MOs
resulted in a higher percentage of affected embryos (increasing from 75% to 100%) at 24
hpf (Online Table II). This dose-dependent effect of the lrp1a MO was specific to the
knockdown of lrp1a RNA and not due to activation of the p53-dependent cell death
pathway22(Online Figure VC–F, Table II–III and Movie I–III). Knockdown of the second
lrp1 gene (lrp1b, ENSDART00000088208, chr. 23), either alone or with lrp1a resulted in a
similar vascular phenotype, suggesting that the lrp1 genes possess redundant functions
(Online Figure VG).
Pi et al. Page 7










Next, we investigated whether the vascular defect of lrp1 morphant fish is cell-autonomous
by performing cell transplantation assays. Control or lrp1 MO-injected ‘donor’ cells were
transplanted into wild-type recipient embryos. We observed that both control and lrp1 MO-
injected cells contributed to blood, endothelial structures (dorsal aorta (DA), cardinal vein,
CV plexus (CVP) and intersegmental vessel (Se)) and other structures (somite, notochord,
etc.) similarly (data not shown), suggesting that lrp1 MO did not affect cell differentiation
during development. lrp1 MO-injected cells were excluded from the tip cell position within
venous network located in the CVP and participated in fewer ventral sprouting events
(Figure 5C, D, Online Figure VH). However, there was no obvious defect in the injected
cell’s ability to contribute to the tip cell within the Se, which is predominantly arterial in
nature at this developmental stage. Bmp signaling was recently reported to regulate the
ventral sprouting from the axial vein12. This finding, together with our data, suggests that
LRP1, similar to Bmp, regulates vein development in a cell-autonomous fashion. The
cardiovascular defects observed in LRP1 morphant fish might be due to non-autonomous
effects of LRP1 and reflect the autonomous requirement of LRP1 in venous endothelial
function.
Bmper knockdown in zebrafish leads to diminished levels of Smad1/5/8 phosphorylation
and a dorsalized phenotype consisting of defects in hematopoiesis and vascular patterning,
reflecting the role that Bmper-mediated Bmp signaling plays during embryo gastrulation and
vascular development23,5. Since the pattern of lrp1a in the developing zebrafish embryo
mirrors that of bmper, we examined the effect of lrp1a knockdown on Bmper-mediated Bmp
signaling in lrp1a MO-injected Tg(kdrl:EGFP)s843 fish using immunohistochemical
localization of Smad1/5/8 phosphorylation. In wild-type fish, LRP1 expression was
localized to the DA, CV and caudal artery (CA), whereas the expression of LRP1 protein
was significantly reduced in lrp1a morphant fish (Figure 5E). In wild-type fish, the signal
for phosphorylated Smad1/5/8 was mainly localized to the DLAV, DA, CA, and some at Se
and CV (Figure 5F). In contrast, lrp1a knockdown decreased Smad1/5/8 phosphorylation in
these regions (Figure 5F), indicating that LRP1, similar to Bmper, is required for Bmp-
dependent events in vascular development.
DISCUSSION
The data presented in this report is a continuation of our previous work designed to elucidate
the molecular mechanisms involved in Bmper regulation of Bmp signaling. Here we present
data supporting a model in which LRP1 acts as an endocytic receptor for Bmper, facilitating
the formation and internalization of the Bmp4/BMPR signaling complex. Receptor
endocytosis plays a critical role not only in the control of receptor protein levels at the cell
surface and in the regulation of signaling pathways24. Similar to the case of endocytosis of
TGFβ and EGF24, we believe that, in the case of Bmp4 signaling, clathrin-coated pits and
early endosomes are signaling compartments, whereas late endosomes and lysosomes are
sites where signaling is eventually blocked. Furthermore, our data support a model in which
the magnitude and rate of LRP1-dependent endocytosis and the association of LRP1 and
Bmp receptors, regulated by the Bmper:Bmp4 stoichiometric ratio, are critical factors
determining the endocytic route of the Bmp4 signaling complex.
Previous studies have demonstrated that regulators of Bmp signaling modulate Bmp
signaling using a spatial gradient effect that covers the distance of many cells25. In contrast,
our data suggest that the mechanism for Bmper’s regulation of Bmp4 signaling operates at
the single cell level and involves a negative feedback loop within the same cell. For
example, when Bmp4 is released it is bound by extracellular Bmper that initially is
substoichiometric. Bmp4 together with Bmper binds to BMPRs and is subsequently
endocytosed and recycled via an LRP1-dependent mechanism, which promotes the
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activation of Bmp4 signaling. Bmp signaling results in a plethora of cellular responses,
including upregulation of Bmper expression26. As Bmp4 signaling continues, more Bmper
is released into the extracellular environment until the intercellular concentration of Bmper
eventually exceeds that of Bmp4. When this happens, the endocytosed Bmper/Bmp4/ALK6
complex is routed to lysosomes where it is degraded, thereby resulting in inhibition of Bmp4
signaling. In this way, each cell involved in the Bmp4 signaling event responds in a tightly
controlled manner.
Although the focus of this report has been the effect of LRP1 on Bmp4 signaling, it is
entirely possible that Bmper/Bmp4 may also have an effect on LRP1 signaling. More than
40 ligands have been identified for LRP1, encompassing multiple cellular functions such as
the regulation of lipid metabolism, cell migration, blood-brain barrier integrity and neuronal
homeostasis14. Our observation that both Bmper and ALK6 bind to the β chain of LRP1,
which is responsible for ligand uncoupling14, raises the interesting possibility that Bmper
and Bmps may influence the signaling mechanisms carried out by LRP1. This is an
intriguing thought, especially given the evidence that LRP1 regulates atherosclerosis via
modulation of PDGF and TGF–β receptor functions14. A potential interaction or
competition between previously identified LRP1 signaling pathways and Bmp-mediated
pathways remains a topic of future research.
We have demonstrated that LRP1, through its effect on Bmp signaling, is essential for
cardiovascular development in zebrafish. The expression pattern of lrp1 in developing
embryos is remarkable for several reasons. lrp1 is expressed in regions known for their high
Bmper/Bmp activity and areas of known vasculogenesis5. This pattern places lrp1 at a time
and location in which it could interact with Bmper and therefore mediate Bmper/Bmp
signaling. This observation is confirmed by the similar phenotype of lrp1- and bmper-
deficient fish. Knockdown of either lrp1 or bmper leads to a similar abnormality in vascular
development, such as the compromised caudal vein plexus and aberrant intersegmental
vessels. However, bmper morphants also exhibit a reduced number of gata1 expressing
hematopoietic precursor cells and circulating blood cells5. Whereas these cell types were
distributed in a disorganized pattern in lrp1 morphants, the actual cell number remained
similar to wild-type embryos. The subtle differences in the expression pattern and
knockdown phenotype of LRP1, compared to Bmper, could be attributed to the activation of
LRP1 by its other ligands.
Collectively, our data suggest that LRP1 plays a requisite role in Bmper-mediated regulation
of Bmp4 signaling by acting as an endocytic receptor for Bmper and mediating the
endocytosis of the Bmper/Bmp4/BMPR complex. Based on these observations, we propose
the following working model to explain the role of LRP1 in the regulation of Bmper-
mediated Bmp4 signaling (Figure 6). In the absence of ligand, ALK6 and LRP1 are
associated, blocking the assembly of an active BMPRII/ALK6 complex (Figure 6A, left).
However, in the presence of Bmp4 (Figure 6A, middle), ALK6 dissociates from LRP1 and
heterodimerizes with BMRPII, The receptor complex is then endocytosed via clathrin-
coated pits in an LRP1-independent manner and sequestered within endosomes where
Bmp4-dependent Smad1/5/8 activation occurs20. When the concentration of Bmper is
substoichiometric, Bmper/LRP1 forms a transient holocomplex with Bmp4/ALK6/BMPRII
(Figure 6B), promoting the Rab4-dependent endocytic fast recycling and therefore
enhancing downstream signaling (Figure 6D). The signaling reaction continues to
completion, possibly by termination of Smad1/5/8 phosphorylation via phosphatase
activation. We speculate that, at the completion of the signaling reaction, the various
components of the Bmper/Bmp4 signaling complex are recycled back to the cell membrane
(Figure 6D, red route), where they would be available for future signaling events. This
pathway would explain the ability of substoichiometric concentrations of Bmper to activate
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Bmp4 signaling. When the concentration of Bmper is suprastoichiometric, the association of
LRP1 with ALK6 increases, but that of ALK6 with BMPRII decreases (Figure 6C). The
LRP1-dependent endocytosis of a transient Bmper/Bmp4/ALK6/LRP1 holocomplex leads to
the degradation of the Bmper/Bmp4 signaling complex and early termination of Bmp4
signaling activity (Figure 6E, green route).
We therefore propose that the different components of the transient Bmp4/Bmper receptor
holocomplex may be the determining factor in deciding which endocytic sorting routes are
used in the presence of sub- versus suprastoichiometric concentrations of Bmper. Bmper
was recently reported to preferentially regulate Bmp9/ALK1 signaling in endothelial cells27.
Whether LRP1 is required for Bmper-modulated Bmp9/ALK1 signaling and how Bmp9
regulates Bmp4/Bmper/BMPR/LRP1 complex formation needs future investigation.
Moreover, the mechanisms behind the receptor-dependent endocytic sorting described
remain unknown. The different components of the transient holocomplex may recruit
different scaffolding proteins, thereby influencing the intracellular route of receptor complex
processing. Alternatively, intracellular routing of the Bmper/Bmp4 signaling complex may
be regulated by post-translational modification of LRP1, which may occur differentially
depending on which components comprise the Bmper/Bmp4 receptor complex. For
example, LRP1 contains an NPxY motif in its cytoplasmic tail that lies proximal to the
plasma membrane. This NPxY motif is a sorting nexin 17 (Snx17) -binding motif that help
sort LRP1-contained endosomes during the receptor recycling process. If this motif is
mutated, LRP1-containing endosomes cannot be recycled and become targets of lysosomal
degradation28. LRP1 endocytosis can also be regulated by a cyclic AMP-dependent protein
kinase A-mediated serine phosphorylation on its cytoplasmic tail29. It is possible that the
different Bmper/Bmp4 receptor complexes formed in the presence of high and low
concentrations of Bmper may influence either the phosphorylation of the LRP1 cytoplasmic
tail or the recruitment of endosome sorting proteins such as Snx17, which in turn may result
in differential intracellular sorting routes. Although additional work is needed to fully
elucidate the exact mechanism for the different sorting processes by which LRP1 regulates
Bmper/Bmp4 signaling, LRP1-dependent endocytosis is clearly critical for all aspects of
Bmper-mediated Bmp4 signaling, and the stoichiometric ratio of Bmper to Bmp4 is a key to
determine whether Bmp signaling is activated or inhibited.
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• Bmp (bone morphogenetic protein) is an essential regulator of endothelial
function.
• Bmper (Bmp endothelial cell precursor-derived regulator) is an important
extracellular modulator of Bmp and regulates Bmp4 activity via a concentration-
dependent, endocytic trap-and-sink mechanism.
What New Information Does This Article Contribute?
• LRP1 (low density lipoprotein receptor-related protein 1) acts as an endocytic
receptor for Bmper and a co-receptor of Bmp4.
• LRP1-dependent endocytosis governs the signaling output of the Bmper/Bmp4
system in endothelial cells and in angiogenesis in vivo.
• Bmper, and possibly other Bmp modulators, functions both extracellularly and
intracellularly to regulate Bmp4 function, allowing regulation of Bmp4 at the
single cell level.
The Bmper/Bmp signaling axis is an important signaling pathway that regulates
endothelial function in both health and disease. In this study, we identified LRP1 as a
novel endocytic receptor of Bmper and a co-receptor of Bmp4 and demonstrated that the
LRP1-dependent endocytosis of Bmper/Bmp4 receptor complex is a crucial molecular
mechanism for both promoting and inhibiting Bmp4 activity by Bmper. Previous studies
have demonstrated that regulators of Bmp signaling, such as Chordin, Noggin and
Gremlin, modulate Bmp signaling using a spatial gradient effect that covers the distance
of many cells. In contrast, our data indicates that Bmper, and possibly these other Bmp
modulators, can work at the single cell level; not only binding Bmp4 and influencing its
interaction with receptors, but also internalizing with the receptor complex to regulate
intracellular signaling. In addition, our data introduce LRP1 as a novel regulator of
endothelial function and vessel development. The knowledge gained from this study will
provide crucial mechanistic information concerning blood vessel formation in health and
disease, and offers novel therapeutic targets and strategies against angiogenesis-related
diseases such as blood vessel ischemic disease, cancer and other related diseases.
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Figure 1. LRP1 associates with Bmper
(A) Lysates of Bmper-treated MECs were immunoprecipitated with an anti-Bmper antibody
and stained with Coomassie blue to identify proteins. (B) Bmper-treated MECs (5 nmol/L
for 1 minute) were stained with anti-Bmper and LRP1 antibodies and examined using
confocal imaging. Scale bar: 10 μm. (C) Lysates of MECs were immunoprecipitated with
anti-LRP1 antibody or mouse control IgG and analyzed by Western blotting with an
biotinylated anti-Bmper antibody. (D) Non-denatured lysates of MECs were analyzed for
ligand blotting. The membrane was incubated with recombinant Bmper and immunoblotted
with anti-Bmper antibody (left panel). LRP1 and RAP1 interaction8 is included as a positive
control. (E) Non-denatured lysates of HEK 293 cells transfected with mLRP1-4 were
analyzed for ligand blotting with an anti-Bmper antibody (right top panel). Right bottom
panel is included as a loading control. Left panel is a schematic representation of LRP1 and
each mLRP1-4 construct.
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Figure 2. LRP1 is required for Bmper endocytosis
(A) Time course of non-denatured cell lysates from Bmper-treated MECs (6 nmol/L) were
analyzed by Western blotting. (B) Quantification of Bmper protein band intensity in A. *,
compared to non-treated control sh-MECs, P<0.02, n=3; #, compared to LRP1-knockdown
MECs treated similarly, P<0.05, n=3. (C) Non-denatured cell lysates from MECs treated
with increasing doses of Bmper were analyzed by Western blotting. (D) Quantification of
Bmper protein band intensity in C. *, compared to non-treated control sh-MECs, P<0.05; #,
compared to LRP1-knockdown MECs treated similarly, P<0.02, n=3. (E) Bmper-treated
MECs (15 minutes) were analyzed by confocal imaging for the co-localization of Bmper
(green), LRP1 (red) and EEA1 (purple), indicated by the arrows. Scale bars: 5 μm.
Pi et al. Page 16










Figure 3. The association of LRP1 and ALK6
(A) A schematic representation of wild type ALK6, its deletion mutants- ALK6-CTD and
ALK6-PKD, and LRP1β constructs. (B) HEK 293 cells were transfected with CFP-ALK6
and YFP-mLRP2 and analyzed by FRET. The calibration bar indicates fluorescence signal
level with white being highest intensity in normalized FRET channel (NFRET). Scale bar:
10 μm. (C) Lysates of HEK 293 cells transfected with plasmids encoding Flag-ALK6-WT
and HA-mLRP1~4 were immunoprecipitated with an anti-Flag antibody and analyzed by
Western blotting. * indicates precursor ‘ER’ and fully glycosylated ‘Golgi’ forms of
mLRPs15. (D) Lysates of HEK293 cells transfected with HA-ALK6-WT and Flag-LRP1β
were immunoprecipitated with anti-HA or Flag antibody and analyzed by Western blotting.
(E) Lysates of HEK 293 cells transfected with Flag-ALK6-CTD/PKD and HA-mLRP2 were
immunoprecipitated with an anti-Flag antibody and analyzed by Western blotting.
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Figure 4. LRP1-mediated endocytosis is required for the Bmper-dependent regulation of Bmp4
downstream signaling
(A) Endocytosis is required for both promoting- and inhibiting Bmp function of Bmper.
MECs were pretreated with CPM or CQ and then treated with Bmp4 (0.6 nmol/L) and
Bmper for 15 minutes (CPM) or 120 minutes (CQ) at 10 nmol/L (Bmper alone); 0.3 nmol/L
(“BB-sub” = sub-stoichiometric Bmper); 10 nmol/L (“BB-supra” = Bmper
suprastoichiometric). Cell lysates were analyzed by Western blotting. (B) Rab4 is required
for Smad1/5/8 phosphorylation induced by Bmp4 and substoichiometric Bmper. Lysates of
MECs transfected with control or Rab4 siRNA and treated with Bmp4 and Bmper (15
minutes) were analyzed by Western blotting. (C) LRP1 is required for Bmper/Bmp
internalization and Bmper-dependent Bmp downstream signaling. Lysates of LRP1-
knockdown or control MECs treated with Bmp4 and Bmper (30 minutes) were analyzed by
Western blotting. (D) Lysates of MECs treated with Bmp4 and Bmper for 15 minutes were
immunoprecipitated with an anti-BMPRII antibody and analyzed by Western blotting. (E)
The association of LRP1 and ALK6 is regulated upon the different treatment of Bmp4 and
Bmper. Lysates of MECs following Bmp4 and Bmper treatments for 15 minutes were
immunoprecipitated with the mouse anti-LRP1β antibody and analyzed by Western blotting.
(F) MECs were subjected to the in vitro Matrigel angiogenesis assay. *, compared to the
same MECs at control condition, P<0.05. #, compared to the same MECs treated with
Bmp4, P<0.01. n=3. Scale bar: 100 μm.
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Figure 5. LRP1 is required for cardiovascular development in zebrafish
(A) RNA expression of lrp1a in a whole-mount zebrafish embryo, analyzed by in-situ
hybridization using an lrp1a-specific antisense probe. The arrow represents the lateral dorsal
aorta (LDA). (B) Loss of lrp1a results in a disrupted vascular phenotype. Images are lateral
views of Tg(kdrl:EGFP)S843 zebrafish embryo tails at 24 hpf. The arrowheads represent the
caudal vein plexus (CVP) with branches; the arrows represent filopodia located on the front
edge of vessel plexus. (C) Quantitative analysis of the donor cells located at the tip cell
region of cardinal vein plexus and contributing to ventral sprouting. *, compared to control
MO-injected donor cells, P≤0.001. n is the number of recipient embryos. (D) Representative
lateral views of wild-type recipient embryos of Tg(kdrl:EGFP)s843 fish tail at 34 hpf.
Confocal imaging was performed. In the control MO-donor cells-transplanted embryo, three
donor cells (white arrows) participated in active ventral sprouting. However, in the lrp1 MO-
donor cells-transplanted embryo, donor cells remained in dorsal or axial vasculature (white
arrowheads). (E, F) Confocal imaging analysis of whole mount Tg(kdrl:EGFP)s843 fish
embryo tails at 48 hpf, with immunostaining for LRP1 (E) and phospho-Smad1/5/8 (F).
Scale bars: 100 μm (A, B, E, F); 50 μm (D).
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Figure 6. A schematic model shows how LRP1 is required for Bmp4/Bmper signaling
(A, left) In the absence of ligand, ALK6 and LRP1 are associated, blocking the assembly of
an active BMPRII/ALK6 complex. In the presence of Bmp4 (A, middle), ALK6 dissociates
from LRP1 and heterodimerizes with BMPRII20. This Bmp4/BMPRII/ALK6 receptor
complex is sequestered within endosomes where Bmp signaling occurs30. (B) When the
concentration of Bmper is substoichiometric, Bmper/LRP1 forms a transient holocomplex of
Bmp/ALK6/BMPRII, which promotes Rab4-dependent endocytic fast recycling and
enhances downstream Bmp signaling (D, red route). (C) When the concentration of Bmper
is suprastoichiometric, the association of LRP1 with ALK6 increases, but that of ALK6 with
BMPRII decreases. The LRP1-dependent endocytosis of a transient Bmper/Bmp/ALK6/
LRP1 holocomplex leads to the degradation of the Bmper/Bmp signaling complex and
termination of Bmp signaling activity (E, green route).
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